DEVIVO JOSEPH sold $1.4M of BFLY

DEVIVO JOSEPH (President & CEO) sold 211,798 shares of Butterfly Network, Inc. (BFLY) at $6.56 ($1.39M total) on 2026-07-20.

Original reporting
SEC EDGAR · DEVIVO JOSEPH
Published Jul 21, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and can influence short-term sentiment, but it does not introduce new guidance, contracts, or regulatory developments.

02

Market read

Traders may monitor whether additional insider activity follows, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

The article does not state tax, diversification, or planned sale rationale, and it provides no follow-on buying or guidance changes.

Relevance 6/10Novelty 5/10Timing: Filed 2026-07-21, covering a sale executed 2026-07-20.

Background

The article is an SEC Form 4 insider transaction disclosure for Butterfly Network, Inc.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

SEC Form 4 shows CEO DEVIVO JOSEPH sold 211,798 shares of Butterfly Network at $6.56 on 2026-07-20.

Expected impact

Likely limited near-term impact; any effect is more about sentiment and positioning than new company fundamentals.

Evidence & confidence

The filing is primary-source and time-stamped, but it provides no new operational, financial, or regulatory information beyond the sale details.

Market effects

No direct sector read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

CEO sales can be routine liquidity management and may not reflect bearish expectations, especially without a 10b5-1 plan disclosed.

Key entities

  • Butterfly Network, Inc.

    Subject of the Form 4 insider sale by its President and CEO.

  • DEVIVO JOSEPH

    President and CEO who sold 211,798 shares at $6.56 on 2026-07-20.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BFLYHigh

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network (BFLY) reported Q3 record gross profit of $23.8M, up from a $3.8M loss last year. Adjusted EBITDA loss narrowed to $1.2M. Full-year 2026 revenue guidance raised to $123M-$126M. Company plans international strategy shift and expects FedRAMP authorization to boost government business. Cash reserves at $122M.

$BFLYMed

Butterfly (BFLY) Q3 2026 Earnings Call Transcript

Butterfly (BFLY) reported Q3 2026 revenue of $32.6M, beating guidance by 9%. The company raised full-year guidance and highlighted growth in U.S. enterprise contracts and international expansion. Key developments include FedRAMP authorization for federal government contracts and new partnerships in brain-computer interface and healthcare applications.

$BFLYMed

Butterfly Network, Inc. Q3 2026 Earnings Call Summary

Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.

$BFLYMed

Butterfly Network Reports Third Quarter 2026 Financial Results

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million, driven in part by Embedded revenue • Recorded highest gross margin in Company history at 73

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.